Faculty & Scientific Staff

Jan Beck, MSc, is an executive and investor in the pharmaceutical and biotech industries with over 20 years of professional experience from multinational companies in Europe and the United States. Throughout his career journey, Jan has focused on establishing financial and operational systems in complex and dynamic business environments for long-term strategic decision making. He has a proven track record of leading teams of professionals in business expansions that have resulted in multimillion-dollar cost savings, revenue increases, and acquisitions.

As a partner in EMB Investment Group, Jan drives early-stage investments in biotech and business start-ups and guides rising teams through mentorship and executive support. In his previous role, Jan served as chief operating officer at Mozart Therapeutics, a biotech company focused on improving the lives of people living with autoimmune and inflammatory conditions through the discovery and development of new disease-modifying therapies.

Before joining Mozart Therapeutics, Jan led research and development operations at Lyell Immunopharma in Seattle and San Francisco, enabling the organization’s research teams to develop curative cell therapies for solid tumors with a focus on performance, productivity, and operational planning.

From 2017-2022, Jan was president of Novo Nordisk’s Seattle research center, a multimillion-dollar direct investment endeavor that changed the face of biomedical research and built world-class protein technology platforms. Prior to this, Jan directed Novo Nordisk’s Global Business Intelligence Unit and held various international finance and operations roles in Copenhagen, Denmark; Zurich, Switzerland; and Princeton, New Jersey.

Currently, Jan serves on the board of Life Science Washington as well as the Scan Design Foundation, where he supports sustainability projects geared toward promoting U.S.-Danish relations.

Jan holds a master’s degree in business and economics from Copenhagen Business School and has completed Harvard University’s executive leadership program for pharmaceutical executives. He is based in Seattle with his wife Maria and their two children, Amelia and Christian.